Eli Lilly Jumps On Expedited Plans For Alzheimer's Drug, Biogen Falls
June 24, 2021 at 11:14 AM EDT
Eli Lilly announced that the Food and Drug Administration granted Breakthrough Therapy designation for donanemab, its investigational antibody therapy for Alzheimer's disease.
